These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 29423793)

  • 1. What Can We Learn About Human Disease from the Nematode C. elegans?
    Apfeld J; Alper S
    Methods Mol Biol; 2018; 1706():53-75. PubMed ID: 29423793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.
    Silverman GA; Luke CJ; Bhatia SR; Long OS; Vetica AC; Perlmutter DH; Pak SC
    Pediatr Res; 2009 Jan; 65(1):10-8. PubMed ID: 18852689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling human diseases in Caenorhabditis elegans.
    Markaki M; Tavernarakis N
    Biotechnol J; 2010 Dec; 5(12):1261-76. PubMed ID: 21154667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nematode Caenorhabditis elegans as a model to study viruses.
    Diogo J; Bratanich A
    Arch Virol; 2014 Nov; 159(11):2843-51. PubMed ID: 25000902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference in Caenorhabditis elegans: uptake, mechanism, and regulation.
    Zhuang JJ; Hunter CP
    Parasitology; 2012 Apr; 139(5):560-73. PubMed ID: 22075748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined flow cytometry and high-throughput image analysis for the study of essential genes in Caenorhabditis elegans.
    Hernando-Rodríguez B; Erinjeri AP; Rodríguez-Palero MJ; Millar V; González-Hernández S; Olmedo M; Schulze B; Baumeister R; Muñoz MJ; Askjaer P; Artal-Sanz M
    BMC Biol; 2018 Mar; 16(1):36. PubMed ID: 29598825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling human peroxisome biogenesis disorders in the nematode Caenorhabditis elegans.
    Thieringer H; Moellers B; Dodt G; Kunau WH; Driscoll M
    J Cell Sci; 2003 May; 116(Pt 9):1797-804. PubMed ID: 12665560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide RNAi screens in Caenorhabditis elegans: impact on cancer research.
    Poulin G; Nandakumar R; Ahringer J
    Oncogene; 2004 Nov; 23(51):8340-5. PubMed ID: 15517014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomic approaches in C. elegans.
    Lamitina T
    Methods Mol Biol; 2006; 351():127-38. PubMed ID: 16988431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genomic approaches using the nematode Caenorhabditis elegans as a model system.
    Lee J; Nam S; Hwang SB; Hong M; Kwon JY; Joeng KS; Im SH; Shim J; Park MC
    J Biochem Mol Biol; 2004 Jan; 37(1):107-13. PubMed ID: 14761308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caenorhabditis elegans, a model organism for kidney research: from cilia to mechanosensation and longevity.
    Müller RU; Zank S; Fabretti F; Benzing T
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):400-8. PubMed ID: 21537177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-animal high-throughput screens: the C. elegans model.
    O'Rourke EJ; Conery AL; Moy TI
    Methods Mol Biol; 2009; 486():57-75. PubMed ID: 19347616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic kidney diseases: Caenorhabditis elegans as model system.
    Ganner A; Neumann-Haefelin E
    Cell Tissue Res; 2017 Jul; 369(1):105-118. PubMed ID: 28484847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant worms: what cancer research can learn from C. elegans.
    Saito RM; van den Heuvel S
    Cancer Invest; 2002; 20(2):264-75. PubMed ID: 11901546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C. elegans as a model for human inherited degenerative diseases].
    Ségalat L; Néri C
    Med Sci (Paris); 2003 Dec; 19(12):1218-25. PubMed ID: 14691746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and genetic characterization of osmosensing and signal transduction in the nematode Caenorhabditis elegans.
    Choe KP; Strange K
    FEBS J; 2007 Nov; 274(22):5782-9. PubMed ID: 17944943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caenorhabditis elegans: nature and nurture gift to nematode parasitologists.
    Salinas G; Risi G
    Parasitology; 2018 Jul; 145(8):979-987. PubMed ID: 29208057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic target discovery using Caenorhabditis elegans.
    Link EM; Hardiman G; Sluder AE; Johnson CD; Liu LX
    Pharmacogenomics; 2000 May; 1(2):203-17. PubMed ID: 11256592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.